Leptin levels were also correlated with a better prognosis in patients with colorectal cancer and leptin was reported to inhibit hepatocellular carcinoma proliferation in vitro through the p38-MAPK-dependent signaling pathway [231]. The gene discussed is LEP; the disease is hepatocellular carcinoma.